Skip to content
PeptideAgent

Are peptides legal in Washington?

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The short answer

Yes. A Washington resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Washington-licensed prescriber, including by telehealth under the Uniform Telehealth Act (chapter 18.134 RCW, enacted 2024), and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Washington Pharmacy Quality Assurance Commission. Nonresident pharmacies need a Washington license under RCW 18.64.360 backed by an approved inspection report, and every licensee that compounds must follow the USP chapters adopted in WAC 246-945-100.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Sep 22, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a Washington resident get peptides by telehealth?

Washington adopted the Uniform Telehealth Act in 2024 (chapter 18.134 RCW). RCW 18.134.010 defines telehealth as synchronous or asynchronous telecommunication technology used to provide care to a patient at a different location. Under RCW 18.134.030 a practitioner-patient relationship may be established through telehealth, but not through email, instant messaging, text messaging, or fax. RCW 18.134.040 holds telehealth care to the same professional practice standards as comparable in-person care and bars disciplining authorities from adopting different standards just because care is delivered by telehealth. RCW 18.134.050 generally requires an out-of-state practitioner to hold a Washington license, with narrow exceptions for consultation and follow-up care of established patients who are temporarily in Washington. Asynchronous technology is within the definition, but because the relationship cannot be formed by messaging or a text-based exchange, whether a first prescription can rest on an asynchronous intake alone is not settled, so this record marks it as unresolved. GLP-1 medicines and the peptides in this database are not controlled substances. [2]

How does the Washington pharmacy board treat compounding?

Compounding regulator for Washington
BoardWashington Pharmacy Quality Assurance Commission (Washington State Department of Health)
Eligible substancesFollows the federal 503A framework

In Washington the pharmacy regulator is a commission rather than a board: the Pharmacy Quality Assurance Commission (PQAC) regulates the practice of pharmacy and the distribution of drugs within and into the state under chapter 18.64 RCW and its consolidated rule chapter, WAC 246-945. WAC 246-945-100 requires every licensee that compounds sterile or non-sterile preparations to comply with the applicable USP chapters (795, 797, 800, and 825). RCW 18.64.360 requires nonresident pharmacies to be licensed and to submit a current inspection report from an approved state or third-party program; the Commission accepts reports from non-approved states only for pharmacies that do not compound. Washington has no separate state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [3] [4] [5] [7]

Can you get compounded GLP-1s in Washington?

Regulatory: Compounded GLP-1 limited

Because a nonresident pharmacy that compounds must supply an inspection report from an approved program to keep its Washington license, patients can confirm eligibility through the Department of Health provider credential search. [1] [4] [10]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Washington?

Verified access options

Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.

Find a provider in Washington

Is it legal to buy research peptides in Washington?

Chapter 69.41 RCW makes it unlawful to sell, deliver, or possess a legend (prescription) drug except on a valid prescription or as otherwise authorized (RCW 69.41.030), and pharmacy distribution into Washington requires Commission licensure under chapter 18.64 RCW. [3] [6] [11]

Peptide-specific notes for Washington

Peptide-specific notes for Washington
PeptideNote
BPC-157Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. The Pharmacy Quality Assurance Commission has not published a peptide-specific rule. [1] [8] [9]

Frequently asked questions

Can I get a GLP-1 prescription in Washington through telehealth?

Yes. Under the Uniform Telehealth Act (chapter 18.134 RCW) a Washington-licensed practitioner can establish a relationship with you through telehealth and prescribe under the same standards as an in-person visit. [2]

Can a Washington telehealth relationship start over text or email?

No. RCW 18.134.030 says a practitioner-patient relationship may not be established through email, instant messaging, text messaging, or fax. [2]

Does an out-of-state telehealth prescriber need a Washington license?

Generally yes. RCW 18.134.050 requires a Washington license, with narrow exceptions for consultation, specialty assessment, or follow-up care for established patients who are temporarily in Washington. A new GLP-1 patient in Washington needs a Washington-licensed prescriber. [2]

What does an out-of-state compounding pharmacy need to ship to Washington?

A Washington nonresident pharmacy license under RCW 18.64.360, supported by a current inspection report from an approved state or third-party program. Pharmacies that compound cannot rely on reports from non-approved states, and all compounding must follow the USP chapters in WAC 246-945-100. [4] [5]

Is it legal to buy research peptides online in Washington?

Not for human use. RCW 69.41.030 bars selling or delivering a legend drug without a valid prescription, and "research use only" injectable peptides are unapproved new drugs under federal law that are not dispensed by a licensed pharmacy. [6] [11]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.

  1. [1]Washington Pharmacy Quality Assurance Commission (Department of Health)
  2. [2]Chapter 18.134 RCW, Uniform Telehealth Act
  3. [3]Chapter 18.64 RCW, Pharmacists
  4. [4]RCW 18.64.360, Nonresident pharmacies
  5. [5]Chapter 246-945 WAC, Pharmacy Quality Assurance Commission (including WAC 246-945-100, compounding minimum standards)
  6. [6]RCW 69.41.030, Sale, delivery, or possession of legend drug without prescription or order prohibited
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  9. [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, September 22). Are peptides legal in Washington?. https://peptideagent.ai/legal/washington
HTML link
<a href="https://peptideagent.ai/legal/washington">Are peptides legal in Washington?</a>, PeptideAgent, updated September 22, 2026.